Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Abbott Laboratories Add to portfolio

INX:ABT, Jul 15, 10:32 UTC

Latest INX:ABT News

Filter your feed

Apply Filter

Monday, July 13


News

Abbott Laboratories must understand that Africa has changed especially with Covid 19

ABT

Abbott Laboratories must understand that Africa has changed especially with Covid 19. We are not surprised at Abbott’s assertion that it is unaware of claims arising out of the company wilfully breaching contracts, failure to deliver Covid test kits, using politically exposed persons to circumvent contracts with suppliers (serious compliance violations), and, ultimately, preventing African governments from helping the poor at this critical time. Abbott acknowledged receipt of the lead claimants’ initial notice with respect to its dealings in two African countries on 19 June 2020, through Bassem Bibi, Vice President & General Manager, Abbott Rapid Diagnostics EM Africa, and is now in receipt of notices with respect to claims amounting to over US$50 million in 3 countries, with other claims currently being consolidated. We do not take this case lightly because African Lives do Matter, especially when it comes to the fight against Covid 19. While we will not comment further on the substance of the case, we will continue to use every legal means to get justice and to hold Abbott Laboratories accountable.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Abbott Laboratories must understand that Africa has changed especially with Covid 19

ABT

Abbott Laboratories must understand that Africa has changed especially with Covid 19. We are not surprised at Abbott’s assertion that it is unaware of claims arising out of the company wilfully breaching contracts, failure to deliver Covid test kits, using politically exposed persons to circumvent contracts with suppliers (serious compliance violations), and, ultimately, preventing African governments from helping the poor at this critical time. Abbott acknowledged receipt of the lead claimants’ initial notice with respect to its dealings in two African countries on 19 June 2020, through Bassem Bibi, Vice President & General Manager, Abbott Rapid Diagnostics EM Africa, and is now in receipt of notices with respect to claims amounting to over US$50 million in 3 countries, with other claims currently being consolidated. We do not take this case lightly because African Lives do Matter, especially when it comes to the fight against Covid 19. While we will not comment further on the substance of the case, we will continue to use every legal means to get justice and to hold Abbott Laboratories accountable.Distributed by APO Group on behalf of Centurion Law Group.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Friday, July 10


News

Top Analyst Reports for Oracle, Abbott & Chevron

ABT CVX +1 more ABT CVX ORCL

Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Abbott Laboratories (ABT) and Chevron (CVX). You can see all of today’s research reports here >>>. Oracle shares have underperformed the Zacks Computer Software industry over the past year (-4.1% vs. +36.1%), but the Zacks analyst sees a better long-term trajectory for the company given rapid adoption of data cloud solutions and Autonomous Database. Moreover, companies like 8x8 and Zoom Video Communications have selected Oracle Cloud Infrastructure services to address business needs, which is a testament to the strength of its cloud offerings. Solid demand for the Oracle Dedicated Region Cloud@Customer supported by ML is anticipated to drive the top line. Although the company’s shares have underperformed in the past year, these factors are expected to help it grow in the rest of 2020. However, coronavirus crisis led business impacts remain an overhang on renewals and payments. The Zacks analyst believes that the supermajor’s reserve replacement ratio of 44% is indicative of its inability to add proved reserves to its reserve base to the amount of oil and gas produced.

Read Full Details

Topics:
  • Business
  • Financial

Monday, July 06


News

Abbott Deal, UnitedHealth Coverage Push Up Tandem Shares

ABT UNH

Two leaders in the diabetes market are teaming up to provide a better way to administer insulin to patients. Abbott Laboratories (NYSE:ABT) and Tandem Diabetes Care Inc. (NASDAQ:TNDM) have finalized an agreement to marry their respective continuous glucose monitors and digital insulin delivery systems, according to an article in FierceBiotech. The announcement helped push the shares of San Diego-based Tandem to a one-year high of nearly $106, more than doubling its 52-week low. In addition to the Abbott deal, Tandem got a big boost last week when UnitedHealth Group Inc. (UNH) announced in a bulletin that the country's largest health insurer is now covering insulin pumps from Tandem in network for members on Medicare Advantage, Medicaid and individual and group market plans, according to Medtech Dive.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

DETAILED EXAMINATION OF THE Impact of Covid-19 on Allergy Diagnostics market 2020: BY TOP LEADING VENDORS LIKE Abbott Laboratories, Astra Biotech GmbH – Jewish Market Reports

ABT

DETAILED EXAMINATION OF THE Impact of Covid-19 on Allergy Diagnostics market 2020: BY TOP LEADING VENDORS LIKE Abbott Laboratories, Astra Biotech GmbH. Annual forecasts and estimates for the years 2020 to 2026 were provided in the report, as well as estimates for previous years, for each given segment and sub-segments. The Allergy Diagnostics report consists of streamlined financial data obtained from various research sources to provide specific and reliable analysis. Assessment of key market trends having a positive impact on the market over the next two years, including an in-depth analysis of market segmentation, including sub-markets, on a regional and global basis. Enquire Here For Discount @ https://www.garnerinsights.com/Global-Allergy-Diagnostics-Market-Research-Report-2020-2024#discount. Some of the main geographies included in this study:  North America (United States and Canada and rest of North America) Europe (Germany, France, Italy and rest of Europe)  Asia-Pacific (China, Japan, India, South Korea and the rest of Asia-Pacific) LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and the rest of LAMEA). Some major points addressed in this Allergy Diagnostics market report:.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Monday, June 22


News

As problems grow with Abbott's fast COVID-19 test, FDA standards are under fire

ABT

The warning followed multiple academic studies showing higher “false negative” rates from the Abbott device, including one from New York University (NYU) researchers who found it missed close to half of the positive samples detected by a rival company’s test. But then, in a move that confounded lab officials and other public health experts, a senior FDA official later that month said coronavirus tests provided outside lab settings would be considered useful in fighting the pandemic even if they miss 1 in 5 positive cases—a worrisome failure rate. Though the Abbott rapid test is one of over 100 COVID-19 diagnostic tests to receive FDA emergency use authorization during the pandemic, President Donald Trump has featured the product in the White House Rose Garden, and the Department of Health and Human Services’ (HHS') preparedness and response division has issued more than $205 million worth of contracts to buy the test, according to federal contract records. In its own COVID-19 testing policy for labs and commercial manufacturers, the FDA says a diagnostic test should correctly identify at least 95% of positive samples. But medical professionals are split over the lower 80% threshold for the Abbott and other point-of-care tests’ “sensitivity”—a metric showing how often a test correctly generates a positive result. “Knowing the true performance of such a point-of-care test and knowing that it may be less sensitive than a central lab molecular test is important, but also can play a role in triaging patients who are suspected of having COVID-19,” Timothy Stenzel, M.D., Ph.D., director of the FDA’s Office of In Vitro Diagnostics and Radiological Health, said on the call when discussing the Abbott warning.

Read Full Details

Topics:
  • Business
  • Health
  • Technology
  • Science
News

Baby Formula Nutritions Products Market Forecast to 2027 – Abbott Nutrition, FrieslandCampina, Groupe Danone, Mead Johnson Nutrition, Meiji Holdings Co, Nestlé S.A, Perrigo Company plc – 3w Market News Reports

ABT CPB +2 more ABT CPB BN PRGO

Baby Formula Nutritions Products Market Forecast to 2027 – Abbott Nutrition, FrieslandCampina, Groupe Danone, Mead Johnson Nutrition, Meiji Holdings Co, Nestlé S.A, Perrigo Company plc. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. The research report provides deep insights into the global market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Baby Formula Nutritions Products market? What are the prominent market trends influencing the development of the Baby Formula Nutritions Products market across different regions? What are the major threats and challenges likely to act as a barrier in the growth of the Baby Formula Nutritions Products market? What are the major opportunities the market leaders can rely on to gain success and profitability? Asia Pacific is estimated to be one of the fastest growing markets for Baby Formula Nutritions Products market.

Read Full Details

Story Sources

3wnews.org 3wnews.org
Topics:
  • Business
  • Financial

Tuesday, June 09


News

Impact COVID-19 on Vascular Guidewires Market Along with Major Market Players

ABT BSX

Impact COVID-19 on Vascular Guidewires Market Along with Major Market Players | Abbott Laboratories,Boston Scientific,Cordis,Cook Medical. Global Vascular Guidewires Market Report is a finished appraisal of current market Status, Opportunities, Trends, and individual pieces of the pie of the absolute most conspicuous players in this scene. The investigation contains mindful experiences, realities, chronicled information, and factually bolstered and industry-approved market information. The catchphrase showcase report looks at the financial status and anticipation of worldwide and significant areas, in the possibility all things considered, types and end-client application/ventures; this report analyzes the most striking players in major and worldwide locales, likewise partitions the Vascular Guidewires advertise by portions and applications/end organizations. Solicitation for Sample Copy @ http://www.researchreportsinc.com/report-sample/827722.

Read Full Details

Topics:
  • Business
  • Financial
  • Science
News

What’s driving the Malaria Diagnostics Market Growth? Prominent Players Abbott Laboratories, Access Bio. Inc., Atlas Medical, Biom?rieux SA, Bio-Rad Laboratories

ABT

The global malaria diagnostics market accounted for $728,870 thousand in 2018 and is expected to reach $1,085,106 thousand by 2026, registering a CAGR of 5.1% from 2019 to 2026. Furthermore, surge in awareness initiatives by governments and increase in research for new malaria diagnostics are the factors that boost the growth of the market. However, lack of awareness about healthcare in developing countries is a major factor that restricts the market growth. Region wise, it is analyzed across North America (the U.S., and Canada, and Mexico), Europe (Germany, the UK, and rest of Europe), Asia-Pacific (China, India, and rest of Asia-Pacific), and LAMEA (Africa and rest of LAMEA). Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Malaria Diagnostics Market.

Read Full Details

Topics:
  • Business
  • Health
  • Science

Thursday, June 04


News

Global Cardiac Surgery Devices Market with COVID-19 Impact Analysis, Top Companies like Abbott Laboratories, Medtronic Plc., Statistics, Market Challenges, Opportunities, Size, Share, Growth, Trends, Forecast To 2025 – Biopharmapress

ABT SIE

The report provides an in-depth assessment of growth and other aspects of the market in key countries such as the United States, Canada, Mexico, Germany, France, the United Kingdom, Russia and the United States Italy, China, Japan, South Korea, India, Australia, Brazil and Saudi Arabia. The chapter on the competitive landscape of the global market report contains important information on market participants such as business overview, total sales (financial data), market potential, global presence, Cardiac Surgery Devicessales and earnings, market share, prices, production locations and facilities, products offered and applied strategies. India Cardiac Surgery Devices Market Status and Outlook. Southeast Asia Market Status and Outlook. Nanomedical Devices Market report is a comprehensive analysis of global market has newly added by IT Intelligence Markets to its extensive repository.

Read Full Details

Topics:
  • Business
  • Health
  • Science